Market Overview

The Global Cosmetic Surgery and Services Market was valued at USD 128,630.7 million in 2023 and is expected to reach USD 385,346.9 million by 2031 while growing at a CAGR of 14.7% during the forecast period (2024-2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global cosmetic surgery and services market growth. Cosmetic surgery, a branch of plastic surgery, aims to enhance appearance through surgical and medical techniques, with a focus on improving aesthetic appeal, symmetry, and proportion in different body parts. Generally elective, individuals opt for these procedures for personal reasons rather than medical necessity. The wide-ranging procedures can be performed on various body areas such as the face, neck, breasts, body, and extremities.

Increasing consumer awareness, acceptance, and technological advancements, including minimally invasive procedures, laser treatments, and non-surgical techniques, are expected to propel the growth of the Cosmetic Surgery and Services Market. Nevertheless, challenges like the high cost of procedures and stringent regulatory requirements may hinder market expansion.

Furthermore, the global cosmetic surgery and services industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Treatment Type Analysis

The Global Cosmetic Surgery and Services Market is segmented among Surgical, and Non-Surgical, based on Treatment Type. In 2023, Non-Surgical accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Cosmetic Surgery and Services Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are AbbVie Inc., Bausch Health Companies Inc., Cynosure Technologies, Galderma SA, Laboratories Vivacy SaS, Merz Pharma GmbH & Co. KGaA, Sinclair Pharma PLC, Syneron, Teoxane Laboratories, and Vital Esthetique.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Cosmetic Surgery and Services Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Cosmetic Surgery and Services Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Cosmetic Surgery and Services Market Segmentation, By Treatment Type

• Global Cosmetic Surgery and Services Market Share Analysis, By Treatment Type

• Global Cosmetic Surgery and Services Market Growth Analysis, By Treatment Type

• Global Cosmetic Surgery and Services Market Trends, By Treatment Type

o Surgical

Ø Breast Augmentation

Ø Liposuction

Ø Tummy Tuck

Ø Eyelid Surgery

Ø Breast Lift

o Non-surgical

Ø Botulinum toxin

Ø Dermal Fillers

Ø Laser Hair Removal

Ø Photo-rejuvenation

Ø Microdermabrasion

6. Global Cosmetic Surgery and Services Market Segmentation, By Region

• Global Cosmetic Surgery and Services Market Share Analysis, By Region

• Global Cosmetic Surgery and Services Market Growth Analysis, By Region

• Global Cosmetic Surgery and Services Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

7. Competitive Landscape

• AbbVie Inc.*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Bausch Health Companies Inc.

• Cynosure Technologies

• Galderma SA

• Laboratories Vivacy SaS

• Merz Pharma GmbH & Co. KGaA

• Sinclair Pharma PLC

• Syneron

• Teoxane Laboratories

• Vital Esthetique

 *Similar analysis will be provided for each company listed above.